Tag: Hyperuricemia

By Posted on Posted in Adverse Drug Reaction [ADR], Regulatory Announcement, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , ,

January 16, 2109 – Despite drug safety problems of cardiovascular mortality with Febuxostat (Uloric), the benefits might still be seen to outweigh risks for selected gout patients. This notion may become more and disputed over time, however, for obvious reasons. …

Febuxostat (Uloric) and its problem with cardiovascular mortality Read more »

By Posted on Posted in New Drug Approval, Personalized Medicine, Pharmacogenetics, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , , ,

December 24, 2015 – The American Food and Drug Administration (FDA) just approved Lesinurad  (Zurampic) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a …

Is there help for patients suffering from gout? Lesinurad (Zurampic) approved for the treatment of high blood uric acid levels Read more »